We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Pruritus in Patients With Chronic Kidney Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01727180
Recruitment Status : Completed
First Posted : November 15, 2012
Results First Posted : March 17, 2015
Last Update Posted : March 17, 2015
Sponsor:
Information provided by (Responsible Party):

Study Description
Brief Summary:
We believe that knowing characteristics of uremic pruritus is the foundation to investigate its pathophysiology and offer better skin care for patients with chronic kidney disease. We therefore conducted this cross-sectional study to evaluate the characteristics of uraemic pruritus.

Condition or disease Intervention/treatment
Kidney Failure, Chronic Pruritus Other: Questionnaire based on the McGill Pain Questionnaire

Study Design

Study Type : Observational
Actual Enrollment : 108 participants
Observational Model: Case-Only
Time Perspective: Cross-Sectional
Study Start Date : June 2011
Primary Completion Date : June 2012
Study Completion Date : December 2013

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Groups and Cohorts

Group/Cohort Intervention/treatment
Chronic kidney disease Other: Questionnaire based on the McGill Pain Questionnaire
Interview questionnaire based on the short form of the McGill Pain Questionnaire


Outcome Measures

Primary Outcome Measures :
  1. Visual Analog Scale (VAS) [ Time Frame: Once at the entry of the study ]
    A visual analog scale (VAS) measuring the general severity of pruritus was reported from 0 to 10 (0 = no pruritus, 10 = worst pruritus imaginable


Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   20 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients with CKD stage 3 to 5D, followed-up in the Far Eastern Memorial Hospital
Criteria

Inclusion Criteria:

  • Adults older than 20 years old, with CKD stage 3 to 5D, with symptoms of pruritus.

Exclusion Criteria:

  • Patients who refused to answer the questionnaire or unable to understand the contents of the questionnaire.
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01727180


Locations
Taiwan
Far Eastern Memorial Hospital
New Taipei City, Taiwan, 220
Sponsors and Collaborators
Far Eastern Memorial Hospital
Investigators
Principal Investigator: Hon-Yen Wu, MD Far Eastern Memorial Hospital
More Information

Responsible Party: Far Eastern Memorial Hospital
ClinicalTrials.gov Identifier: NCT01727180     History of Changes
Other Study ID Numbers: 100047-E
First Posted: November 15, 2012    Key Record Dates
Results First Posted: March 17, 2015
Last Update Posted: March 17, 2015
Last Verified: March 2015

Additional relevant MeSH terms:
Renal Insufficiency
Pruritus
Kidney Failure, Chronic
Kidney Diseases
Urologic Diseases
Skin Diseases
Skin Manifestations
Signs and Symptoms
Renal Insufficiency, Chronic